MedTrace Logo

Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy

NCT03690895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2018-10-01

No results posted yet for this study

Summary

This study aims at describing survival rates over time (Kaplan-Meier estimator) in patients suffering from AIDS-related primary central nervous system lymphoma who were diagnosed from 1996 to 2014 and treated with infusions of high-dose methotrexate and combined antiretroviral therapy.

Conditions

  • Central Nervous System Lymphoma
  • AIDS Related Lymphoma

Interventions

OTHER

Retrospective survival analysis

Kaplan-Meier model

Sponsors & Collaborators

  • Fondation Ophtalmologique Adolphe de Rothschild

    lead NETWORK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-15
Primary Completion
2016-10-01
Completion
2016-10-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03690895 on ClinicalTrials.gov